Lisa • October 25, 2023
Dear Lori

Hello readers! I am sharing a letter I wrote to my sister on October 6, 2023 while sitting in a sesson at the Heart Failure Society of America annual scientific session held in Cleveland Ohio. I intended this letter as a way to talk to my sister who passed away in June 1995. For those of you who have lost a loved one, we know we talk to them often, but I felt on this topic I wanted to write a letter – I later read this letter at the HCMA annual meeting. Lori is truly the core of all work done at the HCMA – she is my super power, my guide, my heart and my very loved sister.

Dear Lori,
The day you left us our world shattered. Your children were in pain and it was our job to continue your work to give them roots and wings. Today they are grown, married, successful in their chosen career paths, happy, healthy, and kind humans. You are now the grandmother of 2 beautiful boys. You also are an aunt to my beautiful daughter Rebecca who you felt kick my very pregnant belly as you were in a coma prior to your passing, she was born a month after you left. You also have 3 great nieces who are beautiful young ladies.

Shortly after your passing I was incredibly angry, your death was preventable. I spent years making people, institutions, and policy makers accountable for their failures. I am going to tell you about some of this shortly.

You were 36 when you died, I was 26. Your children are now older than you ever were on earth. I have lived longer without you then with you. It is hard to believe because you have been the most influencetual person in my life.

Every holiday table or party your laugh is missed, your cooking… well it was always a topic of conversation which are also missed. We have missed you so very much in many ways. Everytime I hear Crocodile Rock I see you dancing in your bedroom, 20 years old, beautiful, happy, and full of life.

So why after 10,340 days or 28 years, 3 months, 21 days, am I writing to you? Do you remember the day we say in your house at the dining room table and talked about starting a support group for patients with HCM? Well Sis, I did a “thing”. I want to tell you about it.
I started a non profit organization to address the needs of the hypertrophic cardiomyopathy community and ensure the medical errors that lead to your death end, in short I dedicate my life to keep patients safe, families whole, and advancing clinical care and the science. I admit I am my harshest critic, but after 28 years I can look back and see the efforts have paid off but more work is needed.


The organization is the Hypertrophic Cardiomyopathy Association, we are a board of 12, staff and contractors of 15, 400 volunteers, 50 HCMA Recognized Center of Excellence (COE) programs, over 500 clinicians, researchers, and COE staff. A year ago a fund was created in your name to assist patient with travel to access health care for HCM. The newest challenge yet wonderful one is we are partnering with industry. Lori there are now drug therapies specifically for HCM and many under development. But, what happened this week is something I wasn’t sure I would see in my life. A young woman, 27 years old was given a simple injection in an IV which contained a piece of genetic material to correct the gene mutation that causes HCM, in fact the same mutation that runs in our family MYBPC3. It is early days and only one brave amazing woman, it’s so incredibly inspiring that a cure may someday be possible for some, including your children and grandchildren and mine.
My work isn’t done, in fact in someway it feels like it’s just begun.


Lori – you changed the HCM world, your story is known around the world, patients have found their way to care worldwide because of you and I wanted to let you know what an honor it has been being your sister.

I will write again, I miss you, love you and know someday we will be together again but for now I have lots of work to do down here.

Love,
Lisa

HCMA Blog

April 15, 2025
It is hard to believe the first quarter of 2025 is in the history books. In the space of hypertrophic cardiomyopathy and thick heart muscle disorders, the distance between the promise and the delivery of a reality freed from burden of disease is closer than it has ever been, not only in the United States but throughout the world. Unfortunately, we are navigating through some challenging health policy times, which will impact a large percentage of those with the diseases we seek to serve. While we navigate these challenging waters together, we remain committed to ensuring safe, accessible, affordable, healthcare while ensuring the rights of those with disabilities are maintained. Last month, I attended two large conferences - one held in Stockholm, Sweden the other Chicago, Illinois. The research communities worldwide are holding their breath, waiting to see how we will move forward, even as we continue to develop new therapies, treatments and, even potentially, cures. It has never been more important to keep research moving, as we are so close to so many amazing improvements in our ability to care for those with thick heart muscle disorders, including HCM in all its forms, Amyloidosis, Fabry’s disease, Danon disease, and RASopathies. There was amazing science presented at the American College of Cardiology, where we warmly welcomed new president, Dr Christopher Kramer, the original director of the hypertrophic cardiomyopathy center at University of Virginia. We look forward to his leadership and wish him well in his challenging tasks ahead. Later this month we will be in Orlando Florida - please register and join us for this wonderful Bighearted warrior tour in person with our friends at AdventHealth and the incomparable Dr. Marcos Hazday. I even understand that there's some carpooling being organized from the Tampa area. If you're interested, reach out to the office and we will connect you. Maybe, the most impactful thing that will happen in the month of April is that we will conduct our second visit to Capitol Hill. Our lead topic this year is something you have heard us talk about at many prior meetings of the HCMA and podcasts; the generic drug quality issue. We are proud to be partnering with David Light, Co-founder and President of Valisure, and retired Colonel Vic Suarez, to ask House and Senate members to support the inspection of all generic drugs purchased by the Department of Defense and the Veterans Administration and make results of these inspections open for public use. Secondly, we are seeking rational oversight of health insurance companies’ abuse of prior authorizations and step therapy requirements. These issues cost an estimated 1.3 billion dollars a year and provide nothing to keep a patient safer or a physician's office running more efficiently. Common sense tells us to not waste money where there is no return. Additionally, prior authorizations and step therapies can keep patients sicker longer, ultimately costing the healthcare system more money. Our briefing will educate Representatives to act in an informed manner when moving policies that impact us all. You can watch us live at our briefing Wednesday April 9th 5:00 to 7:00 p.m. on Vimeo: https://vimeo.com/event/5043266 If you wish to get involved or more informed on any of the issues above, I encourage you to visit the website, 4hcm.org , or reach out to the office and the staff will be happy to assist you. On the day before I head out to Washington DC, I will leave you with this one thought - we have come a really long way in our understanding of HCM over the past 60 years. We have increased the lifespan of those with HCM, through collaborative research and implementation of best practices in an organized fashion throughout this country. We have worked so hard to end suffering for so many, and we are succeeding in our shared goal to outsmart hypertrophic cardiomyopathy and other thick heart muscle disorders. It is important to continue the research into all aspects of these diseases, including the biological, the clinical, burden of disease measurements. System improvements, positive impact of timely diagnosis and treatment, and the value to society of all of these big hearts being here, keeping their families whole. So we're off to DC to try to educate others about what it really means to live in our ecosystem. Best wishes, Lisa
Three colored chevrons create a decision flowchart: Identification, Analysis, Evaluation.
By Gordon Fox April 14, 2025
This first in a series post about making decisions as you navigate living with HCM, focuses on the three steps of decision-making: Identification, Analysis, Evaluation.
March 24, 2025
Who should have genetic testing, and when?
More Posts